OUR PRODUCTS

MOBILE APPS

GENERAL INFO

AKBA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Akebia Therapeutics (AKBA) Earnings Date & Reports

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AKBA is expected to report earnings to fall ∞% to -2 cents per share on November 06

Akebia Therapeutics AKBA Stock Earnings Reports

Q3'25

Est.

$-0.03

Q2'25

Beat

by $0.02

Q1'25

Beat

by $0.08

Q4'24

Missed

by $0.03

Q3'24

Missed

by $0.04

The last earnings report on August 07 showed earnings per share of 0 cents, beating the estimate of -1 cents. With 130.75K shares outstanding, the current market capitalization sits at 906.80M.

View a ticker or compare two or three

Compare

AKBA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AKBA
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AKBA showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of drugs for the treatment of anemia and vascular diseases

Industry PharmaceuticalsGeneric

Profile

Fundamentals

Details

Industry

Biotechnology

Address

245 First Street

Phone

+1 617 871-2098

Employees

167

Web

https://www.akebia.com